UNSPSC 51281800: Anthracyclines

This classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.

UNSPSC 51281800 Anthracyclines is a Class code for cancer chemotherapy agents and related pharmaceutical products, though recent state and local procurement activity under this code shows minimal direct relevance to the category's nominal scope. State and local governments do not appear to be actively soliciting anthracycline drugs through tagged opportunities; instead, the few records available show awards and solicitations for unrelated pharmaceutical products—antibiotics (Doxycycline, Ciprofloxacin) and emergency-response medications (Naloxone, drug deactivation systems)—that fall outside the anthracycline therapeutic class. When activity does occur under this code, it takes the form of piggyback awards through multi-state pharmaceutical consortiums (such as MMCAP Infuse) and county-level health procurement, typically handled as invitations for bid (IFB) with fixed pricing and annual renewal options. Issuing bodies include state health departments and county health authorities managing emergency preparedness and community health supply chains.

Recent state and local opportunities tagged to this code show sparse and geographically dispersed activity. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (a completed award, not an open solicitation) valued at $2,999,999.11 over 12 months plus renewals, and Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026 for annual procurement of Naloxone and drug deactivation systems, due July 26, 2023. The code shows minimal activity suitable for vendors focused on anthracycline supply or oncology pharmaceutical procurement.